Medtronic plc has received U.S. Food and Drug Administration (FDA) clearance for its Stealth AXiS™ surgical system. The platform integrates planning, navigation, and robotics into a single system for spine surgery. The Stealth AXiS™ system is cleared for spine procedures in the United States and is designed to support future cranial and ENT applications, pending additional regulatory clearance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via PR Newswire (Ref. ID: CG87554) on February 13, 2026, and is solely responsible for the information contained therein.